Biomed-Lublin Bonds, FRN 22sep2019, PLN (A) (FIGI BBG00B8NX4D7, PLBMDLB00026)
Domestic bonds, Variable rate, Restructuring, Senior Unsecured
Domestic bonds, Variable rate, Restructuring, Senior Unsecured
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get accessBond parameters,
prospectuses
Analyze the data in the most efficient way
Current & historical quotes from 400+ stock exchanges & OTC market
Credit ratings, financial reports
Explore the most comprehensive database
1 000 000
bonds
80 234
stocks
167 970
ETF & Funds
70 000
indices
Track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register|
The current employment level in the company amounts to approximately 230 persons (mostly partners). The staff are well qualified specialists, with many years of experience in manufacturing. However, the company welcomes young people and each year ...
The current employment level in the company amounts to approximately 230 persons (mostly partners). The staff are well qualified specialists, with many years of experience in manufacturing. However, the company welcomes young people and each year new people successfully complete the recruitment process.
Our own technologies are mostly applied in manufacturing. In the course of over 60 years of operation “Biomed” has become specialized in the manufacturing of many desirable therapeutic preparations, valued for many years both by doctors and patients. The company follows the idea “Your health is most important for us” and it was adopted as its own mission statement.
The main range of the company's activity is the national pharmaceutical market. Besides that the company registers the produced preparations in several European and Asian countries. The products comply with all quality requirements concerning pharmaceuticals. “Biomed” is a holder of the GMP certificate and certificates of free trade. As well as manufacturing activity, it also carries out scientific activity, and has started and maintains cooperation with numerous research centres and independent institutes in Poland and abroad.
|
|
|
|
|
Explore the most comprehensive database
1 000 000
bonds
80 234
stocks
167 970
ETF & Funds
70 000
indices
Track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register